Actor JK (2007). Elsevier's Integrated Immunology and Microbiology. Mosby Incorporated.

Asfaw A, Ali D, Eticha T, Alemayehu A, Alemayehu M, Kindeya F (2015) . CD4 Cell Count Trends after Commencement of Antiretroviral Therapy among HIV-Infected Patients in Tigray, Northern Ethiopia: A Retrospective Cross-Sectional Study. PLoS ONE 10(3): e0122583. 
Crossref

Bastard M, Soulinphumy K, Phimmasone P, Saadani AH., Ciaffi L, Communier A, Phimphachanh C, Ecochard R, Etard JF (2013). Women experience a better long-term immune recovery and a better survival on HAART in Lao People's Democratic Republic. BMC Infectious Diseases 13(1):27.
Crossref

Central Statistical Agency [Ethiopia] and ORC Macro (2012). Ethiopia Demographic and Health Survey 2011: Addis Ababa, Ethiopia, and Calverton, Maryland, USA: Central Statistical Agency and ORC Macro.

Gezie LD, Gelaye KA, Worku AG, Ayele TA, Teshome DF (2017). Time to immunologic recovery and determinant factors among adults who initiated ART in Felege Hiwot Referral Hospital, Northwest Ethiopia. BMC Research Notes 10(1):277.
Crossref

Joint United Nations Programme on HIV/AIDS (UNAIDS): Report on the global AIDS epidemic, 2012, "UNAIDS / JC2417E".

Kelley CF, Kitchen CM, Hunt PW, Rodriguez B, Hecht FM, Kitahata M, Crane HM, Willig J, Mugavero M, Saag M, Martin JN (2009). Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clinical Infectious Diseases 48(6):787-794.
Crossref

Kumar AM, Gupta D, Kumar A, Gupta RS, Kanchar A, Rao R, Shastri S, Suryakanth MD, Rangaraju C, Naik B, Guddemane DK., Bhat P, Nair AS, Harries AD, Dewan P (2017). HIV-infected presumptive tuberculosis patients without tuberculosis: How many are eligible for antiretroviral therapy in Karnataka, India? Journal of Epidemiology and Global Health 71:11-19.
Crossref

Lawn SD, Myer L, Bekker L, Wood R (2006). CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa, BMC Infectious Diseases 6:59.
Crossref

MacLennan CA, Liu MK, White SA, van Oosterhout JJ, Simukonda F, Bwanali J, Moore MJ, Zijlstra EE, Drayson MT, Molyneux ME (2007). Diagnostic accuracy and clinical utility of a simplified low cost method of counting CD4 cells with flow cytometry in Malawi: Diagnostic accuracy study. British Medical Journal 335(7612):190-190.
Crossref

Malaza A, Mossong J, Ba¨rnighausen T, Viljoen J, Newell M-L (2013). Population-Based CD4 Counts in a Rural Area in South Africa with High HIV Prevalence and High Antiretroviral Treatment Coverage. PLoS ONE 8(7):e70126. 
Crossref

Moges Derbe, Monga DP, Deresse Daka (2013). Immunological response among HIV/AIDS patients before and after ART therapy at Zewuditu Hospital Addis Ababa, Ethiopia. American Journal of Research Communication 1(1):103-115 View

Molla AA, Gelagay AA, Mekonnen HS, Teshome DF (2018). Adherence to antiretroviral therapy and associated factors among HIV positive adults attending care and treatment in University of Gondar Referral Hospital, Northwest Ethiopia. BMC Infectious Diseases 18(1):266. Published 2018 Jun 8.
Crossref

Moore DM, Harris R, Lima V, Hogg B, May M, Yip B, Justice A, Mocroft A, Reiss P, Lampe F, Chêne G, Costagliola D, Elzi L, Mugavero MJ, Monforte AD, Sabin C, Podzamczer D, Fätkenheuer G, Staszewski S, Gill J, Sterne JA, Antiretroviral Therapy Cohort Collaboration (2009). Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression. Journal of Acquired Immune Deficiency Syndromes 52(3):357-63
Crossref

Reda AA, Biadgilign S, Deribew A, Gebre B, Deribe K (2013). Predictors of Change in CD4 Lymphocyte Count and Weight among HIV Infected Patients on Anti-Retroviral Treatment in Ethiopia: A Retrospective Longitudinal Study. PLoS ONE 8(4):e58595
Crossref

Seoane E, Resino S, Micheloud D, Moreno A, Juan CL, Lorente R, Rubio R, Gonzalez J, Pulido F, Arribas JR, Moreno S (2008). Lipid and apoprotein profile in HIV-1-infected patients after CD4-guided treatment interruption. Journal of Acquired Immune Deficiency Syndromes 48(4):455-459.
Crossref

Smith CJ, Sabin CA, Youle MS, Kinloch-de Loes S, Lampe FC, Madge S, Cropley I, Johnson MA, Phillips AN (2004). Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy. The Journal of Infectious Diseases 190(10):1860-1868.
Crossref

Tiba F, Nauwelaers F, Traoré S, Coulibaly B, Ouedraogo T, Compaoré A, Kräusslich HG, Böhler T (2012). Immune reconstitution during the first year of antiretroviral therapy of HIV-1-infected adults in rural Burkina Faso. The Open AIDS Journal 6:16.
Crossref

Zhou J, Sirisanthana T, Kiertiburanakul S, Chen YMA, Han N, Lim P, Kumarasamy N, Choi JY, Merati TP, Yunihastuti E, Oka S (2010). Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: Results from The TREAT Asia HIV Observational Database. BioMed Central Infectious Diseases 10(1):361.
Crossref